Global X Management Company LLC ("Global X"), the New York-based provider of exchange-traded funds (ETFs), today announced ...

PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...

Statement Pursuant to Section 19(a) of the Investment Company Act of 1940 DENVER, CO / ACCESS Newswire / March 31, 2025 / On ...

The AI hardware build out is continuing, but investors also need to understand how the new technology is helping businesses ...

Kinetics The Global Fund earns an Above Average Process Pillar rating. The leading factor in the rating is its parent firm's superior long-term risk-adjusted performance, as shown by the firm's ...

A third of the Global Fund for HIV, TB and Malaria’s money comes from the United States. The other contributions come from ...

Gates Foundation officials have previously said “no foundation” can effectively replace the U.S. government’s foreign aid funding.

Class A shares at net asset value underperformed the MSCI All-Country World Growth Index but outperformed the Morningstar ...

The Global Fund for HIV, TB and Malaria says it will fund the roll-out of the twice-yearly anti-HIV jab, lenacapavir, for poorer countries, including South Africa, with or without the help of the ...

administers the Global Fact Fund. The mission of the Fund is to strengthen the operational and engagement capacities of local and regional media organizations to increase the impact of fact ...

The management team's focus on value and risk management has helped the First Eagle Global Fund weather market storms and enhance its performance over recent years. Nvidia Corp. (NVDA) has ...

The Global Fund to Fight AIDS, Tuberculosis and Malaria says it will fund the rollout of the twice-yearly anti-HIV jab, lenacapavir, for poorer countries, including South Africa, with or without the ...